We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
(+22%)
Cap. Flow
+$29.9B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Revvity
RVTY
$13.1B
| $5.68M | ﹤0.01% |
58,658
+40,802
| +229% | +$3.92M |
|
1502
HEICO Corp Class A
HEI.A
$38.1B
| $5.65M | ﹤0.01% |
22,393
+5,216
| +30% | +$1.29M |
|
1503
Alliant Energy
LNT
$18.2B
| $5.65M | ﹤0.01% |
86,874
+2,564
| +3% | +$172K |
|
1504
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $5.64M | ﹤0.01% |
120,537
+26,526
| +28% | +$1.25M |
|
1505
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $5.63M | ﹤0.01% |
47,136
+2,148
| +5% | +$255K |
|
1506
Fulton Financial
FULT
$4.69B
| $5.63M | ﹤0.01% |
291,100
+54,112
| +23% | +$996K |
|
1507
Alamo Group
ALG
$1.99B
| $5.62M | ﹤0.01% |
33,507
-696
| -2% | -$121K |
|
1508
Taboola.com
TBLA
$1.06B
| $5.62M | ﹤0.01% |
1,219,679
+277,061
| +29% | +$1.04M |
|
1509
Gray Television
GTN
$520M
| $5.62M | ﹤0.01% |
1,161,583
+19,288
| +2% | +$94.4K |
|
1510
JFrog
FROG
$11.5B
| $5.62M | ﹤0.01% |
89,991
+8,379
| +10% | +$476K |
|
1511
Compass
COMP
$10.2B
| $5.6M | ﹤0.01% |
529,768
-243,041
| -31% | -$2.22M |
|
1512
Alight
ALIT
$394M
| $5.6M | ﹤0.01% |
143,572
+94,233
| +191% | +$4.69M |
|
1513
1st Source
SRCE
$2.13B
| $5.6M | ﹤0.01% |
89,536
+20,597
| +30% | +$1.27M |
|
1514
Itron
ITRI
$4.5B
| $5.59M | ﹤0.01% |
60,241
-22,052
| -27% | -$2.4M |
|
1515
ADMA Biologics
ADMA
$2.11B
| $5.59M | ﹤0.01% |
306,207
+31,048
| +11% | +$523K |
|
1516
Materion
MTRN
$5.88B
| $5.58M | ﹤0.01% |
44,885
-786
| -2% | -$96.9K |
|
|
VRE
1517
DELISTED
Veris Residential
VRE
| $5.55M | ﹤0.01% |
373,064
+190,092
| +104% | +$2.81M |
|
1518
Pebblebrook Hotel Trust
PEB
$2.05B
| $5.55M | ﹤0.01% |
489,955
+34,533
| +8% | +$380K |
|
|
UCTT
1519
Ultra Clean Holdings
UCTT
$4.21B
| $5.54M | ﹤0.01% |
218,663
-18,401
| -8% | -$490K |
|
1520
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $5.54M | ﹤0.01% |
192,008
+7,011
| +4% | +$203K |
|
1521
Vanda Pharmaceuticals
VNDA
$304M
| $5.53M | ﹤0.01% |
627,006
-41,460
| -6% | -$228K |
|
1522
Mesa Laboratories
MLAB
$633M
| $5.51M | ﹤0.01% |
70,138
+37,499
| +115% | +$2.85M |
|
1523
Hamilton Lane
HLNE
$5.91B
| $5.5M | ﹤0.01% |
40,947
+36,450
| +811% | +$4.58M |
|
1524
Costamare
CMRE
$1.74B
| $5.5M | ﹤0.01% |
348,140
+10,807
| +3% | +$149K |
|
1525
BioCryst Pharmaceuticals
BCRX
$2.51B
| $5.49M | ﹤0.01% |
704,291
-295,494
| -30% | -$2.14M |
|
Similar funds
AQR Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
- AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
- AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.